- Investing.com
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through Health & Medical, Consumer Goods, and Professional Hygiene segments. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, wet wipes, wash gloves, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family caregivers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce. The Consumer Goods segment provides pads, panty liners, tampons, diapers, shampoos, lotions, baby oil, skin creams, intimate soaps, intimate wipes, leakproof apparel, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins under the TENA, Knix, Modibodi, Libero, Lotus, Drypers, Libresse, Bodyform, Nana, Saba, Nosotras, Nuvenia TOM Organic, Tempo, Zewa, Cushelle, Plenty, Regio, Colhogar, and Familia brands through retail trade and e-commerce. The Professional Hygiene segment offers toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products, as well as vision cleaning and data-driven cleaning solutions under the Tork brand to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues through direct to the end-customer, e-commerce, or via distributors. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
Metrics to compare | ESSITYb | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipESSITYbPeersSector | |
---|---|---|---|---|
P/E Ratio | 21.8x | 18.4x | 11.7x | |
PEG Ratio | 0.19 | 0.41 | 0.03 | |
Price/Book | 2.6x | 2.4x | 1.5x | |
Price / LTM Sales | 1.5x | 1.3x | 0.9x | |
Upside (Analyst Target) | 4.3% | 20.7% | 18.2% | |
Fair Value Upside | Unlock | 22.6% | 9.1% | Unlock |